510(k) K162208
K162208 is an FDA 510(k) premarket notification submitted by Beckman Coulter, Inc. for the device "DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent". The FDA issued a decision of Substantially Equivalent on January 9, 2017. The device falls under product code CFN (Method, Nephelometric, Immunoglobulins (G, A, M)), a Class II device regulated under 21 CFR 866.5510. Beckman Coulter, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 9, 2017
- Date Received
- August 5, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Method, Nephelometric, Immunoglobulins (G, A, M)
- Device Class
- Class II
- Regulation Number
- 866.5510
- Review Panel
- IM
- Submission Type